Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1289, pseudogene (RNU6-1289P)
- Target
- RNU6-1289P
- Molecular classification
- Other, Pseudogene, Small nuclear RNA (snRNA)-related
01
Overview
RNU6-1289P is a pseudogene related to U6 small nuclear RNA, which plays a critical role in pre-mRNA splicing as part of the spliceosome in eukaryotes[1][3]. The U6 family consists of highly conserved non-coding RNAs involved in post-transcriptional processing, but RNU6-1289P itself is annotated as a non-functional pseudogene and is not known to have direct biological activity. Pseudogenes generally do not produce functional proteins or RNAs, although in some cases, pseudogene transcripts can regulate gene expression by acting as competing endogenous RNAs, miRNA sponges, or through other RNA-mediated mechanisms[4]. There is no evidence that RNU6-1289P plays a specific functional, pathogenic, or pharmacological role.
- Other names
- RNU6-1289PRNA, U6 small nuclear 1289, pseudogene
02
Mechanism of action
None applicable
03
Biological functions
OtherMay participate in non-coding RNA regulatory networks if transcribed, via mechanisms such as antisense regulation, miRNA decoy activity, or competing endogenous RNA roles (functions described for other pseudogenes, generalizable but unconfirmed for this specific locus)
04
Disease associations
None established for RNU6-1289P specificallyIn general, pseudogenes can be involved in diseases such as cancer, immune regulation, and other contexts if they are expressed and functional[4]. However, there are no reports of RNU6-1289P being a disease biomarker or implicated in pathology.
Beyond the preview
Go deeper on RNA, U6 small nuclear 1289, pseudogene (RNU6-1289P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 1289, pseudogene (RNU6-1289P).